RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger 
Trump Threatens 100% Tariffs on Countries Imposing Digital Services Taxes on U.S. Tech Firms 
Trump Administration Closes Delta Air Lines Investigation Over 2024 CrowdStrike Outage 
US Dollar Slips After PCE Inflation Data as Fed Rate Hike Expectations Stay Elevated 
Iran Skips U.S. Technical Talks Over Unmet MoU Conditions and Frozen Funds Dispute 
Yen Falls to 40-Year Low as Markets Watch Japan Intervention and U.S. Jobs Report 
Apple Challenges India Antitrust Probe, Says CCI Copied Rivals’ Claims in App Store Case 
China Expands Export Controls, Adds 20 Japanese Companies to Restricted List 
RBA Minutes Signal Australia Central Bank Remains Ready to Raise Interest Rates if Inflation Persists 
Trump Signs Memorandum Backing Americans’ Right to Repair Their Own Vehicles 
Russia Intensifies Assault on Kostiantynivka as Ukraine’s Donetsk Defense Faces Mounting Pressure 
Trump Urges Gasoline Retailers to Cut Prices to $2.50 Per Gallon, Warns of Legal Action 
Despite its best efforts, Iran won’t be able to toll the Strait of Hormuz. Here’s why 
US Stock Futures Steady as Investors Await Payrolls Data and Monitor Iran Tensions 
China Sets 1.25% Overnight Reverse Repo Rate Below Market Expectations 
U.S. Launches Trade Investigation Into Germany’s Pharmaceutical Cost-Cutting Plans 
Ukraine Strikes Russian Titan-Barrikady Plant With Long-Range FP-5 Flamingo Missile 
One year after his sweeping "Liberation Day" tariff announcements, President Donald Trump has introduced a new wave of trade measures targeting pharmaceutical imports and restructuring duties on steel, aluminum, and copper.
Under a national security proclamation, foreign drugmakers selling patented products in the U.S. must negotiate price reductions with the government and commit to shifting some manufacturing stateside — or face steep consequences. Companies that fulfill both conditions avoid tariffs entirely. Those that only move partial production to the U.S. will face a 20% levy, while companies that do neither will be hit with a 100% tariff. Large pharmaceutical firms have 120 days to comply, while smaller producers are given 180 days. Select trade partners — including the EU, Japan, South Korea, Switzerland, and the UK — receive capped or zero-rate deals under separate agreements.
On the metals front, Trump signed a proclamation cutting tariff rates on derivative steel, aluminum, and copper products in half to 25%, while removing duties altogether on goods with less than 15% metal content by weight. The base 50% tariff on raw commodity imports remains, though its application will now be tied to U.S. sales prices rather than declared import values — a move designed to close valuation loopholes. Certain industrial and power-grid equipment will see duties reduced to 15% through 2027.
The announcements came as the administration works to replace IEEPA-based tariffs struck down by the Supreme Court in February, which had generated roughly $166 billion in collected duties now subject to refunds.
Reactions remain divided. The U.S. Chamber of Commerce warned the pharmaceutical tariffs would raise healthcare costs, while metals industry groups praised the updated framework as more precisely targeted. Trade Representative Jamieson Greer defended the broader tariff strategy as a long-term driver of domestic production and wage growth.
